Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

The 64 drugs (PDF) with reduced co-insurance costs for Medicare patients include ... CMS announced discounts on 10 popular drugs like Enbrel, Jardiance and Januvia, starting in 2026.

More than 110,000 North Carolinians are projected to benefit from a $2,000 annual cap on out-of-pocket costs for covered prescription drugs for Medicare Part D participants.

After years of delays and debate, 2024 was the year when several health initiatives started to move forward. And advocates ...

Medicare, in collaboration with Medicaid, has negotiated with pharmaceutical companies to reduce the prices of ten high-cost, ...

Adding CKD to the label for Jardiance (empagliflozin ... Hospitalisations account for up to 70% of total healthcare costs for people with CKD, according to EU data. Leonard Glass, senior vice ...

SGLT-2 inhibitors include empagliflozin (Jardiance) and dapagliflozin (Farxiga), and GLP-1 agonists include semaglutide (Ozempic) and liraglutide (Victoza). "The use of these evidence-based ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

With list prices of $8.94 per day for the monotherapy and metformin combinations, the companies are hoping to gain ground on Farxiga and Jardiance by undercutting them – Farxiga costs $11.57 per ...